About Us – PathoPrint
Revolutionizing AMR Diagnostics with AI
At PathoPrint, we are on a mission to combat antimicrobial resistance (AMR) by leveraging the power of artificial intelligence (AI). With drug-resistant infections rising globally, we aim to provide data-driven diagnostic solutions that empower hospitals, labs, and healthcare professionals to make informed treatment decisions.
The Global AMR Crisis
- 1.27 million deaths per year are directly caused by AMR (The Lancet, 2022).
- By 2050, AMR could surpass cancer, causing up to 10 million deaths annually (WHO).
- The economic burden of AMR is projected to reach $100 trillion globally (World Bank).
Pakistan’s Growing AMR Challenge
- 70% of bacterial infections in Pakistan are resistant to common antibiotics (NIH Pakistan, 2023).
- Urinary Tract Infections (UTIs): 60% are caused by E. coli, with 50% resistance to ciprofloxacin (PMC, 2024).
- 45% of Klebsiella pneumoniae infections are resistant to last-resort carbapenems (WHO GLASS, 2024).
What We Do
PathoPrint is developing an AI-powered platform that integrates Culture & Sensitivity (C/S) test data with machine learning to:
- Predict bacterial resistance trends in real-time.
- Provide smart antibiotic recommendations for optimized treatment.
- Assist doctors, labs, and policymakers with data-driven AMR insights.
- Support hospitals and healthcare institutions in tackling AMR effectively.
Our Mission
To revolutionize infection treatment by delivering AI-powered AMR diagnostics that improve patient care, reduce antibiotic misuse, and support global efforts in fighting AMR.
Why PathoPrint?
- AI-Powered Precision Real-time, data-driven AMR predictions.
- Healthcare Impact Helping hospitals & labs improve patient outcomes.
- Collaborative Approach Working with research institutions, governments, and medical professionals to create an intelligent AMR surveillance system.
Join Us in the Fight Against AMR
We are actively seeking partnerships with hospitals, labs, research institutions, and public health organizations to build the most advanced AI-powered AMR diagnostic tool.
- Want to collaborate?
- Contact us to explore partnerships and pilot programs.
- Interested in our research?
- Join our network of experts fighting AMR with AI-driven innovation.
